Generate Biomedicines Inc (GENB) Return on Equity ROE from the second quarter 2026 to second quarter and annually, average high and low, overall ranking from Jun 30 2026 to - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Generate Biomedicines Inc   (GENB)

Generate Biomedicines Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Generate Biomedicines Inc in the second quarter 2026?
Generate Biomedicines Inc recorded a cumulative net loss of $-230 million during 12 months ending in the second quarter 2026, resulting in a negative return on equity (ROE) of -259.27%.

Within the Major Pharmaceutical Preparations industry Generate Biomedicines Inc achieved the highest return on equity. While the total ranking for ROE unchanged, relative to the first quarter 2026 at no. .

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Equity Change - - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -230 -163 -101 -44 0
Return On Equity (TTM) -259.27 % - - - -
GENB's Total Ranking # # # # #
Equity (TTM) in Millions 456 515 -616 0 0
Seq. Equity Change -11.41 % - - - -
Seq. Net Income Change - - - - -

Back to GENB Management Effectiveness >> GENB's 5 Years Annual ROE >> Compare GENB ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





GENB Annual Return On Equity




Total Equity in Millions 0 0 0 0 0
Y / Y Equity Change - - - - -
Net Income in Millions 0 0 0 0 0
Y / Y Net Income Change - - - - -
Return On Equity - - - - -

Back to GENB Management Effectiveness >> GENB's 5 Years Annual ROE >> Compare GENB ROE to its Competitors




More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
GENB's' Return on Equity at Yahoo Finance
GENB's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for GENB's Competitors
Subscribers only: Roe for Generate Biomedicines Inc 's Suppliers
Subscribers only: Return On Equity for GENB's Customers




Companies with similar Return On Equity at Jun 30 2026, within Healthcare Sector ROE

Date modified: 2026-09-26T07:43:57+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.